Cargando…
Corrigendum to “Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway” [Redox Biol. 52 (2022) 102288]
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257208/ https://www.ncbi.nlm.nih.gov/pubmed/37202250 http://dx.doi.org/10.1016/j.redox.2023.102738 |
| _version_ | 1785057256714272768 |
|---|---|
| author | Cai, Chen Guo, Zhongzhou Chang, Xing Li, Ziying Wu, Feng He, Jing Cao, Tiantian Wang, Kangrong Shi, Nengxian Zhou, Hao Toan, Sam Muid, David Tan, Ying |
| author_facet | Cai, Chen Guo, Zhongzhou Chang, Xing Li, Ziying Wu, Feng He, Jing Cao, Tiantian Wang, Kangrong Shi, Nengxian Zhou, Hao Toan, Sam Muid, David Tan, Ying |
| author_sort | Cai, Chen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10257208 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102572082023-06-11 Corrigendum to “Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway” [Redox Biol. 52 (2022) 102288] Cai, Chen Guo, Zhongzhou Chang, Xing Li, Ziying Wu, Feng He, Jing Cao, Tiantian Wang, Kangrong Shi, Nengxian Zhou, Hao Toan, Sam Muid, David Tan, Ying Redox Biol Corrigendum Elsevier 2023-05-16 /pmc/articles/PMC10257208/ /pubmed/37202250 http://dx.doi.org/10.1016/j.redox.2023.102738 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Corrigendum Cai, Chen Guo, Zhongzhou Chang, Xing Li, Ziying Wu, Feng He, Jing Cao, Tiantian Wang, Kangrong Shi, Nengxian Zhou, Hao Toan, Sam Muid, David Tan, Ying Corrigendum to “Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway” [Redox Biol. 52 (2022) 102288] |
| title | Corrigendum to “Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway” [Redox Biol. 52 (2022) 102288] |
| title_full | Corrigendum to “Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway” [Redox Biol. 52 (2022) 102288] |
| title_fullStr | Corrigendum to “Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway” [Redox Biol. 52 (2022) 102288] |
| title_full_unstemmed | Corrigendum to “Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway” [Redox Biol. 52 (2022) 102288] |
| title_short | Corrigendum to “Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway” [Redox Biol. 52 (2022) 102288] |
| title_sort | corrigendum to “empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the ampkα1/ulk1/fundc1/mitophagy pathway” [redox biol. 52 (2022) 102288] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257208/ https://www.ncbi.nlm.nih.gov/pubmed/37202250 http://dx.doi.org/10.1016/j.redox.2023.102738 |
| work_keys_str_mv | AT caichen corrigendumtoempagliflozinattenuatescardiacmicrovascularischemiareperfusionthroughactivatingtheampka1ulk1fundc1mitophagypathwayredoxbiol522022102288 AT guozhongzhou corrigendumtoempagliflozinattenuatescardiacmicrovascularischemiareperfusionthroughactivatingtheampka1ulk1fundc1mitophagypathwayredoxbiol522022102288 AT changxing corrigendumtoempagliflozinattenuatescardiacmicrovascularischemiareperfusionthroughactivatingtheampka1ulk1fundc1mitophagypathwayredoxbiol522022102288 AT liziying corrigendumtoempagliflozinattenuatescardiacmicrovascularischemiareperfusionthroughactivatingtheampka1ulk1fundc1mitophagypathwayredoxbiol522022102288 AT wufeng corrigendumtoempagliflozinattenuatescardiacmicrovascularischemiareperfusionthroughactivatingtheampka1ulk1fundc1mitophagypathwayredoxbiol522022102288 AT hejing corrigendumtoempagliflozinattenuatescardiacmicrovascularischemiareperfusionthroughactivatingtheampka1ulk1fundc1mitophagypathwayredoxbiol522022102288 AT caotiantian corrigendumtoempagliflozinattenuatescardiacmicrovascularischemiareperfusionthroughactivatingtheampka1ulk1fundc1mitophagypathwayredoxbiol522022102288 AT wangkangrong corrigendumtoempagliflozinattenuatescardiacmicrovascularischemiareperfusionthroughactivatingtheampka1ulk1fundc1mitophagypathwayredoxbiol522022102288 AT shinengxian corrigendumtoempagliflozinattenuatescardiacmicrovascularischemiareperfusionthroughactivatingtheampka1ulk1fundc1mitophagypathwayredoxbiol522022102288 AT zhouhao corrigendumtoempagliflozinattenuatescardiacmicrovascularischemiareperfusionthroughactivatingtheampka1ulk1fundc1mitophagypathwayredoxbiol522022102288 AT toansam corrigendumtoempagliflozinattenuatescardiacmicrovascularischemiareperfusionthroughactivatingtheampka1ulk1fundc1mitophagypathwayredoxbiol522022102288 AT muiddavid corrigendumtoempagliflozinattenuatescardiacmicrovascularischemiareperfusionthroughactivatingtheampka1ulk1fundc1mitophagypathwayredoxbiol522022102288 AT tanying corrigendumtoempagliflozinattenuatescardiacmicrovascularischemiareperfusionthroughactivatingtheampka1ulk1fundc1mitophagypathwayredoxbiol522022102288 |